SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

VOLTAN, Rebecca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.410
AS - Asia 3.906
EU - Europa 2.689
SA - Sud America 676
AF - Africa 103
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 14.793
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.267
SG - Singapore 1.476
CN - Cina 932
IT - Italia 891
BR - Brasile 531
VN - Vietnam 499
DE - Germania 383
HK - Hong Kong 309
PL - Polonia 290
UA - Ucraina 239
GB - Regno Unito 224
TR - Turchia 203
FI - Finlandia 154
FR - Francia 120
JP - Giappone 104
RU - Federazione Russa 92
IN - India 77
CA - Canada 74
ID - Indonesia 74
SE - Svezia 69
NL - Olanda 66
AR - Argentina 61
MX - Messico 50
BD - Bangladesh 49
ZA - Sudafrica 41
IQ - Iraq 28
ES - Italia 27
PK - Pakistan 25
LT - Lituania 20
EC - Ecuador 18
CZ - Repubblica Ceca 17
BE - Belgio 16
CO - Colombia 15
UZ - Uzbekistan 15
CL - Cile 14
VE - Venezuela 14
EE - Estonia 13
TN - Tunisia 13
AT - Austria 11
IE - Irlanda 10
KR - Corea 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
KE - Kenya 9
SA - Arabia Saudita 9
MA - Marocco 8
MY - Malesia 8
PY - Paraguay 8
RO - Romania 8
AU - Australia 7
AZ - Azerbaigian 7
TW - Taiwan 7
AL - Albania 6
CR - Costa Rica 6
CY - Cipro 6
IL - Israele 6
IR - Iran 6
JO - Giordania 6
PE - Perù 6
PH - Filippine 6
EG - Egitto 5
KG - Kirghizistan 5
UY - Uruguay 5
BO - Bolivia 4
CH - Svizzera 4
ET - Etiopia 4
LB - Libano 4
OM - Oman 4
TH - Thailandia 4
BG - Bulgaria 3
GE - Georgia 3
GR - Grecia 3
JM - Giamaica 3
NG - Nigeria 3
NI - Nicaragua 3
NP - Nepal 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TZ - Tanzania 3
DK - Danimarca 2
HN - Honduras 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
LV - Lettonia 2
LY - Libia 2
MD - Moldavia 2
PS - Palestinian Territory 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
DO - Repubblica Dominicana 1
GD - Grenada 1
Totale 14.779
Salva come PNG Salva come JPEG
Città #
Singapore 927
Ashburn 902
Fairfield 722
Woodbridge 603
San Jose 485
Houston 404
Beijing 339
Chandler 303
Ferrara 303
Hong Kong 301
Seattle 292
Santa Clara 284
Warsaw 282
Ann Arbor 279
Cambridge 268
Jacksonville 268
Dallas 249
Wilmington 247
Ho Chi Minh City 156
Los Angeles 141
Munich 123
New York 120
Hanoi 116
Council Bluffs 106
Milan 95
Tokyo 95
Izmir 89
Nanjing 82
Boardman 73
Lauterbourg 71
Bologna 63
Princeton 61
Jakarta 58
Helsinki 54
São Paulo 52
Shanghai 49
San Diego 48
Turku 47
Orem 41
London 40
Rome 31
Brooklyn 30
Poplar 30
Buffalo 29
Chicago 29
Dong Ket 29
Johannesburg 29
Mexico City 29
Falls Church 27
The Dalles 27
Da Nang 26
Denver 26
Montreal 26
Frankfurt am Main 25
Bremen 24
Nanchang 23
Boston 22
Istanbul 21
Shenyang 21
Toronto 20
Mersin 19
Chennai 18
Hebei 18
Haiphong 17
Rio de Janeiro 17
Atlanta 16
Brussels 16
Dearborn 16
Hefei 16
Brno 15
Changsha 15
Manchester 15
Phoenix 15
Ankara 14
Tashkent 14
Norwalk 13
Tallinn 13
Tianjin 13
Amsterdam 12
Brasília 12
Kunming 12
Moscow 12
San Francisco 12
Washington 12
Florence 11
Jiaxing 11
Naples 11
Nuremberg 11
Stockholm 11
Hải Dương 10
New Delhi 10
Ninh Bình 10
Biên Hòa 9
Guangzhou 9
Mountain View 9
Mumbai 9
Orange 9
Parma 9
Tappahannock 9
Turin 9
Totale 10.271
Salva come PNG Salva come JPEG
Nome #
Netter's Introduzione all'imaging 345
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 326
Intranasal Administration of Recombinant TRAIL Down-Regulates CXCL-1/KC in an Ovalbumin-Induced Airway Inflammation Murine Model 273
Cell cycle block by p53 acrivation reduces SARS-COV-2 release in infected alveolar basal epithelial A549-hACE2 cells 268
Cell cycle block by p53 activation reduces SARS-CoV-2 release in infected alveolar basal epithelial A549-hACE2 cells 267
MDM2/X inhibitors under clinical evaluation: Perspectives for the management of hematological malignancies and pediatric cancer 266
Expeditious Synthesis and Biological Characterization of Enantio-Enriched (-)-Nutlin-3 266
Anticancer Activity of Aqueous Extracts from Asparagus officinalis L. Byproduct on Breast Cancer Cells 266
Serum From Advanced Heart Failure Patients Promotes Angiogenic Sprouting and Affects the Notch Pathway in Human Endothelial Cells 258
Antitumoral activity of Asparagus officinalis extracts against breast cancer 252
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia 250
Changes in expression profiles of internal jugular vein wall and plasma protein levels in multiple sclerosis 250
Actively targeted nanocarriers for drug delivery to cancer cells 242
HelixComplex snail mucus exhibits pro-survival, proliferative and pro-migration effects on mammalian fibroblasts 236
Coagulation Factor XII Levels and Intrinsic Thrombin Generation in Multiple Sclerosis 235
Multiple dye-doped NIR-emitting silica nanoparticles for both flow cytometry and in vivo imaging 231
Metformin combined with sodium dichloroacetate promotes B leukemic cell death by suppressing anti-apoptotic protein Mcl-1 226
The p53 transcriptional pathway is preserved in ATMmutated and NOTCH1mutated chronic lymphocytic leukemias 223
Clinical perspectives of TRAIL: Insights into central nervous system disorders 222
Characterization Methods for Nanoparticle–Skin Interactions: An Overview 221
Anti-leukemic activity of Dasatinib in both p53 wild-type and p53 mutated B malignant cells 221
The Tat protein broadens T cell responses directed to the HIV-1 antigens Gag and Env: Implications for the design of new vaccination strategies against AIDS 212
Nanoparticles Loaded with Nutlin-3 Display Cytotoxicity Towards p53(wild-type) JVM-2 But Not Towards p53(mutated) BJAB Leukemic Cells 212
Applications of nanoparticles in cancer medicine and beyond: optical and multimodal in vivo imaging, tissue targeting and drug delivery 208
Redox signaling and oxidative stress: Cross talk with TNF-related apoptosis inducing ligand activity 208
The Sorafenib plus Nutlin-3 combination promotes synergistic cytotoxicity in acute myeloid leukemic cells irrespectively of the FLT3 and p53 status 202
Relationship between low levels of circulating TRAIL and atheromatosis progression in patients with chronic kidney disease 197
Priming with a very low dose of DNA complexed with cationic block copolymers followed by protein boost elicits broad and long-lasting antigen-specific humoral and cellular responses in mice 196
Proper design of silica nanoparticles combines high brightness, lack of cytotoxicity and efficient cell endocytosis 195
Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders 190
SRP-35, a newly identified protein of the skeletal muscle sarcoplasmic reticulum, is a retinol dehydrogenase 173
The gamma-secretase inhibitors enhance the anti-leukemic activity of ibrutinib in B-CLL cells 173
Activation of the p53 pathway induces α-smooth muscle actin expression in both myeloid leukemic cells and normal macrophages 165
In Vitro Skin sensitisation analysis by the U-SENS method for new molecules innovative materials and medical devices 159
Rhesus macaque resistance to mucosal simian immunodeficiency virus infection is associated with a postentry block in viral replication 155
Enhanced cellular immunity to SIV Gag following co-administration of adenoviruses encoding wild-type or mutant HIV Tat and SIV Gag. 153
ACE2 up-regulation by MDM2 inhibition reduces inflammation and monocytes adhesion in HUVEC 153
Live recombinant vectors for AIDS vaccine development 152
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets? 152
Asparagus officinalis L. aqueous extracts mediate cell cycle block and migration inhibition in breast cancer cells 150
Replicating Ad-recombinants encoding non-myristoylated rather than wild-type HIV Nef elicit enhanced cellular immunity 150
The oncogene DEK promotes leukemic cell survival and is downregulated by both nutlin-3 and chlorambucil in B-chronic lymphocytic leukemic cells 149
In-vitro anticancer activity of Asparagus officinalis extracts on breast carcinoma 148
Nutlin-3a-loaded ethosomes as an efficient nanodelivery system target p53 in melanoma 147
Perspectives of protein kinase C (PKC) inhibitors as anti-cancer agents 144
p53 and merlin tumor suppressors: Two of a kind 144
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples 143
MCL1 down-regulation plays a critical role in mediating the higher anti-leukaemic activity of the multi-kinase inhibitor Sorafenib with respect to Dasatinib 141
Enhanced Anti-Melanoma Activity of Nutlin-3a Delivered via Ethosomes: Targeting p53-Mediated Apoptosis in HT144 Cells 138
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members 137
Preparation and characterization of innovative protein-coated poly(methylmethacrylate) core-shell nanoparticles for vaccine purposes 132
Nutlin-3 Loaded Ethosomes and Transethosomes to Prevent UV-Associated Skin Damage 128
DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination 123
Cell cycle block by p53 activation reduces SARS-CoV-2 release in A549-hAce2 cells 122
Effects of Nutlin-3a on endothelial cells in the presence of inflammation 119
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin 119
Characterization of HIV-1 Tat proteins mutated in the transactivation domain for prophylactic and therapeutic application 118
In vitro endothelial cell proliferation assay reveals distinct levels of proangiogenic cytokines characterizing sera of healthy subjects and of patients with heart failure 118
Overcoming of Microenvironment Protection on Primary Chronic Lymphocytic Leukemia Cells after Treatment with BTK and MDM2 Pharmacological Inhibitors 118
Nutrients, herbal bioactive derivatives and commensal microbiota as tools to lower the risk of SARS-CoV-2 infection 117
Endothelial cells obtained from patients affected by chronic venous disease exhibit a pro-inflammatory phenotype. 116
MDM2 inhibitors counteract inflammation by stabilization of ACE2 in vitro 115
Ethosomes nanodelivery of the MDM2 inhibitor Nutlin-3a efficiently induces cells death in melanoma 115
Dasatinib plus Nutlin-3 shows synergistic anti-leukemic activity in both p53wild-type and p53mutated B chronic lymphocytic leukemias by inhibiting the Akt pathway. 115
Human Full-Length Osteoprotegerin Induces the Proliferation of Rodent Vascular Smooth Muscle Cells both in vitro and in vivo 109
Nutlin-3 downregulates the expression of the Oncogene TCL1 in primary B Chronic Lymphocytic Leukemic cells. 109
miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells. 107
Role of miRNA in adult ocular tumorigenesis 104
null 103
null 101
null 100
The expression levels of the pro-apoptotic XAF-1 gene modulate the cytotoxic response to Nutlin-3 in B chronic lymphocytic leukemia 99
null 97
Nutlin-3a-loaded ethosomes as a delivery system in vitro to Target p53 in melanoma 94
null 94
null 92
null 90
null 90
null 89
null 88
null 86
null 86
null 84
Oscillatory turbulent flow in chronic venous disease induces pro-inflammatory and reparative biological signaling 83
null 83
Use of bioactives from agrifood by-products in topical cosmetic hydrogels 82
null 81
Nanoparticles engineered with Rituximab and loaded with Nutlin-3 show promising therapeutic activity in B leukemic xenografts 80
Perifosine plus nutlin-3 combination shows a synergistic anti-leukaemic activity. 80
Multi-Step Synthesis of Chimeric Nutlin–DCA Compounds Targeting Dual Pathways for Treatment of Cancer 78
MDM2 inhibitors-mediated disruption of mitochondrial metabolism: A novel therapeutic strategy for retinoblastoma 74
null 74
Anticancer activity of MDM2 inhibition in 2D and bioprinted 3D retinoblastoma cell models 72
Induction of humoral and enhanced cellular immune responses by novel core-shell nanosphere- and microsphere-based vaccine formulations following systemic and mucosal administration 71
Therapeutic potential of the MDM2 inhibitor Nutlin-3 in counteracting SARS-CoV-2 infection of the eye through p53 activation 63
State of the art of the therapeutic perspective of sorafenib against hematological malignancies 62
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines. 60
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3 57
null 55
MDM2 non-genotoxic inhibitors as innovative therapeutic approaches for the treatment of pediatric malignancies 51
Totale 14.893
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.428
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.428
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021210 0 0 0 0 0 0 0 0 0 0 131 79
2021/2022719 25 75 57 37 89 45 44 28 31 54 71 163
2022/2023767 66 48 32 91 108 98 35 66 99 32 56 36
2023/2024544 57 43 20 15 29 74 21 58 17 16 42 152
2024/20252.332 62 75 174 121 296 201 126 130 380 185 301 281
2025/20266.043 579 383 532 765 857 486 709 357 622 735 18 0
Totale 15.009